Physician profile
Jay Paul Logeman
NPI 1538135041
$2,708.29
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $538 · 2021: $713 · 2022: $580 · 2023: $513 · 2024: $42.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $882.24 | 2019-2024 | Grafix Pl, Stravix, Collagenase Santyl |
| Kerecis Limited | $687.87 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $548.19 | 2019-2024 | Puraply |
| Misonix INC | $154.46 | 2020-2021 | |
| Integra Lifesciences Corporation | $138.38 | 2020 | |
| Abbvie INC. | $60.89 | 2021-2022 | |
| Polarityte, INC. | $54.40 | 2019 | |
| Medline Industries LP | $40.93 | 2022 | |
| Bioventus LLC | $36.11 | 2022 | |
| Kci USA, INC. | $33.74 | 2019 | |
| Triad Life Sciences INC. | $24.13 | 2021 | |
| Apria Healthcare LLC | $18.64 | 2021 | |
| Convatec INC. | $15.22 | 2020 | |
| Bsn Medical INC | $13.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Logeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.